Related Articles
LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy
Overexpression of the prolyl isomerase PIN1 promotes cell growth in osteosarcoma cells
Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells
Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell lines Corrigendum in /10.3892/or.2024.8827
Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of osteosarcoma